LUIS ALBERTO
MENCHÉN VISO
Profesor asociado de Ciencias de la Salud
Hospital Miguel Servet
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Miguel Servet (8)
2023
-
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP
Journal of Clinical Medicine, Vol. 12, Núm. 14
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
-
Splanchnic Vein Thrombosis in Inflammatory Bowel Disease: An Observational Study from the ENEIDA Registry and Systematic Review
Journal of Clinical Medicine, Vol. 12, Núm. 23
2021
-
Impact of biological agents on postsurgical complications in inflammatory bowel disease: A multicentre study of geteccu
Journal of Clinical Medicine, Vol. 10, Núm. 19
2013
-
Does smoking influence Crohn's disease in the biologic era? the TABACROHN study
Inflammatory Bowel Diseases, Vol. 19, Núm. 1, pp. 23-29
-
High smoking cessation rate in Crohn's disease patients after physician advice - The TABACROHN Study
Journal of Crohn's and Colitis, Vol. 7, Núm. 3, pp. 202-207
2009
-
Absceso hepático amebiano autóctono en España: ¿una enfermedad emergente? Descripción de 2 nuevos casos clínicos y de una técnica diagnóstica basada en la reacción en cadena de la polimerasa
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 27, Núm. 6, pp. 326-330